Investigating the Relationship Between Anti-seizure Medications and Bleeding Disorders: A Comprehensive Review of the Current Literature
Open Access
- 3 January 2025
- journal article
- review article
- Published by Springer Nature in Drugs - Real World Outcomes
- Vol. 12 (1) , 1-15
Abstract
Anti-seizure medications (ASMs) are specific types of anticonvulsants used to treat epileptic seizures. However, several studies have shown an association between ASMs and an increased risk of hematological disorders, such as thrombocytopenia, aplastic anemia, and platelet function disorders leading to prolonged bleeding times. This review explores the existing literature on this topic, investigating a wide variety of ASMs, ranging from first-generation medications to newer ones. A comprehensive search was conducted on all the currently approved ASMs using PubMed and Google Scholar: review articles, clinical trials, meta-analysis, observational studies, case reports, and relevant animal studies were identified. We extracted 15 ASMs including valproic acid (VPA), carbamazepine, phenytoin, phenobarbital, diazepam, clonazepam, lamotrigine, levetiracetam, oxcarbazepine, felbamate, topiramate, pregabalin, lacosamide, cannabidiol (CBD), and perampanel that contain considerable literature regarding different coagulopathies. An in-depth review of over 140 studies revealed a robust association between ASM-induced changes and the onset of bleeding disorders via several different mechanisms. Polytherapy, the use of multiple ASMs, also emerged as a significant risk factor for the development of coagulopathies. This review highlights the potential link between ASMs and bleeding disorders, emphasizing the importance of considering this risk during treatment planning. By understanding these associations, healthcare providers can optimize patient outcomes and minimize bleeding risks. Additionally, this review identifies the need for further research to bridge current knowledge gaps in clinical pharmacology related to ASMs and bleeding disorders.Keywords
This publication has 147 references indexed in Scilit:
- Oxcarbazepine Does Not Affect the Anticoagulant Activity of WarfarinEpilepsia, 1992
- Characterization of HIV Isolates Arising After Prolonged Zidovudine TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1992
- Valproate Therapy Induces von Willebrand Disease Type IEpilepsia, 1992
- Clinically Significant Hemorrhage Due to Warfarin-Carbamazepine InteractionSouthern Medical Journal, 1990
- Clinically Significant Carbamazepine Drug Interactions: An OverviewEpilepsia, 1987
- Phenytoin, hemorrhage, skeletal defects and vitamin K in the newbornMedical Hypotheses, 1979
- Thrombocytopenia associated with sodium valproate treatmentAnnals of Neurology, 1979
- Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests.1978
- Phenobarbital enhances GABA-mediated postsynaptic inhibition in cultured mammalian neurons.1977
- Anticonvulsivant-induced depression of clotting factors in children.1977